When blood pressure falls below normal levels, hypotension can result, causing dizziness, fainting and fatigue.

Windtree Therapeutics, Inc. (NasdaqCM: WINT) is set to host a virtual Investor Day Presentation on October 1 at 3 pm ET, ...

Cirrhosis is one of the leading causes of mortality from non-communicable diseases, with complications arising as liver ...

Only one is FDA-approved for hair loss. Topical minoxidil is FDA-approved specifically for the treatment of pattern baldness.

USA: Recent findings highlight the role of patiromer in improving treatment outcomes for patients with heart failure and ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S ...

A 48-week clinical trial compared 5% and 2% minoxidil in almost 400 men with male pattern baldness. The 5% minoxidil solution ...

According to GlobalData, there are currently 14 drugs in late-stage development (pre-registration, Phase II, and Phase III) ...

Inc. (Nasdaq: TSVT) today announced that the Company, in partnership with study sponsor Bristol Myers Squibb (BMS), will ...

These results back up results from the TEMPO-3 trial, which tested tavapadon as an add-on therapy to levodopa and which also ...

Ephedra-type alkaloids, a class of naturally occurring compounds derived from plants in the genus Ephedra, have long held ...

Pretreatment with dexamethasone significantly reduced infusion-related reactions in patients receiving amivantamab for advanced lung cancer, according to findings from the SKIPPirr study.